機能的なHPV特異性PD-1+幹細胞のようなCD8T細胞が頭頸がんに
Christiane S Eberhardt1,2,3,4, Haydn T Kissick1,2,5,6, Mihir R Patel5,7
1Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
Nature
|September 2, 2021
まとめ
研究者は,ヒトパピローマウイルス (HPV) に特異的なCD8T細胞を頭頸がんで特定した. 機能的な幹細胞のようなT細胞は,PD-1阻害療法とより広範なHPVワクチン抗原標的の可能性を示しています.
科学分野:
- 免疫学
- 腫瘍学
- ウイルス学
背景:
- T細胞は抗腫瘍免疫に不可欠ですが,ヒトがんにおけるその分化についてはさらなる研究が必要です.
- 抗原特異性T細胞の反応を理解することは,効果的ながん免疫療法の開発の鍵です.
研究 の 目的:
- HPV陽性頭頸がんにおけるヒトパピローマウイルス (HPV) 固有のCD8T細胞の分化と機能を調査する.
- 抗腫瘍免疫を強化するための潜在的な治療標的を特定する.
主な方法:
- 主要組織適合性複合体 (MHC) クラスIテトラマー染色で,HPV特異的なCD8T細胞を特定する.
- T細胞の転写プロフィールを分析するための単細胞RNA配列解析.
- T細胞の増殖と分化を評価するインビトロ刺激アッセイ
主要な成果:
- 3つの異なるHPV特異的なCD8T細胞のサブセットが特定されました:幹細胞のような,一時的な,および末期分化.
- 幹型のHPV特異性CD8T細胞はPD-1とTCF7を表現し,増殖能力を維持し,刺激時にエフェクタ細胞に微分化した.
- 末期分化細胞は限られた増殖を示し,T細胞反応の階層を示唆した.
結論:
- 機能的なHPV特異的なPD- 1+ TCF- 1+幹細胞のようなCD8T細胞は,HPV陽性頭頸部がんに存在し,PD- 1阻害療法をサポートしています.
- ワクチンの抗原としてHPVE2およびE5タンパク質を含めると,腫瘍に対する免疫を高めるためにCD8T細胞の反応が拡大する可能性があります.
さらに関連する動画
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.8K
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
8.7K
関連する概念動画
01:30Cancer Vaccines
570
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
570
01:27Tumor Immunotherapy
759
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
759
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K